Overview

Effect of Preoperative Intravenous Dexamethasone on Postoperative Pain After Primary Total Hip Arthroplasty

Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
0
Participant gender:
All
Summary
To compare the effects of preoperative intravenous Dexamethasone between 10 mg and 40 mg with placebo on Postoperative Pain After Primary Total Hip Arthroplasty
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Chiang Mai University
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Age > 18 years

- Undergoing Elective, Primary, unilateral Total Hip arthroplasty

- American Society of Anesthesiology (ASA) physical class 1-3

- BMI < 40 kg/m2

Exclusion Criteria:

- History of previous musculoskeletal injury on the same hip

- History of prior surgery on the same unilateral hip

- History of adverse effects from medication utilized in this study

- Contraindication to spinal anesthesia

- History of psychiatric disorders or cognitive impairment

- Contraindication to Corticosteroid

- Poorly controlled Diabetes mellitus

- History of ischemic heart disease or peripheral arterial disease or cerebrovascular
disease

- Hepatic insufficiency (Child-Pugh score > 5)

- Renal insufficiency (Creatinine clearance < 30 mL/min)

- History of cataract or glaucoma or ocular hypertension